DURHAM, N.C., FEBRUARY 16, 2018 — Biotech innovators exploring new outsourcing models to develop hematological cancer drugs should attend our February 20 webinar.
Presented by Luke Gill, Vice President Oncology, Clinical Development Services, and Colin Hayward, Chief Medical Officer, Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy will cover the latest research trends in immuno-oncology and gene therapy and examine topics that include:
- The ingredients essential for successful study planning and delivery.
- How to operationalize studies to ensure conclusive data outcomes.
The event begins at 11am EST / 4pm GMT / 5pm CST.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,100 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.